Abstract
STUDY QUESTION
What is the effect of saturated fat ingestion on mononuclear cell (MNC) TNFα, IL-6 and IL-1β secretion and circulating IL-6 levels in women with polycystic ovary syndrome (PCOS)?
SUMMARY ANSWER
Women with PCOS exhibit increases in MNC-derived TNFα, IL-6 and IL-1β secretion and circulating IL-6 following saturated fat ingestion even in the absence of obesity, and these increases are linked to metabolic aberration and androgen excess.
WHAT IS KNOWN ALREADY
Cytokine excess and metabolic aberration is often present in PCOS.
STUDY DESIGN, SIZE, DURATION
A cross-sectional design was used in this study of 38 reproductive-age women.
PARTICIPANTS/MATERIALS, SETTING, METHODS
Groups of 19 reproductive-age women with PCOS (10 lean, 9 obese) and 19 ovulatory controls (10 lean, 9 obese) participated in this study that was performed at a tertiary academic medical centre. TNFα, IL-6 and IL-1β secretion was measured from cultured MNC, and IL-6 was measured in plasma from blood sampling while fasting and 2, 3 and 5 h after saturated fat ingestion. Insulin sensitivity was determined using the Matsuda index following an oral glucose tolerance test. Androgen secretion was evaluated with blood sampling while fasting and 24, 48 and 72 h after an HCG injection.
MAIN RESULTS AND THE ROLE OF CHANCE
Lean and obese women with PCOS exhibited lipid-induced incremental AUC increases in MNC-derived TNFα (489–611%), IL-6 (333–398%) and IL-1β (560–695%) secretion and in plasma IL-6 levels (426–474%), in contrast with lean control subjects. In both PCOS groups, insulin sensitivity was lower (42–49%) and androgen secretion after HCG injection was greater (63–110%) compared with control subjects. The MNC-derived TNFα, IL-6 and IL-1β and circulating IL-6 responses were inversely associated with insulin sensitivity and directly associated with fasting lipids and androgen secretion after HCG injection.
LIMITATIONS, REASONS FOR CAUTION
The sample size of each of the four study groups was modest following group assignment of subjects by body mass.
WIDER IMPLICATIONS OF THE FINDINGS
This study showcases the unique pro-inflammatory contribution of circulating MNC in the development of metabolic aberration and androgen excess in PCOS.
STUDY FUNDING/COMPETING INTEREST(S)
This research was supported by grant R01 DK107605 to F.G. from the National Institutes of Health, the Indiana Clinical and Translational Sciences Institute Clinical Research Center which is funded in part by grant UL1TR002529 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award, and the Indiana University Center for Diabetes and Metabolic Diseases funded by grant P30 DK097512 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. No conflicts of interest, financial or otherwise, are declared by the authors.
TRIAL REGISTRATION NUMBER
ClinicalTrials.gov NCT01489319
COMPARISONS OF GLUCOSE INTOLERANCE TESTING FOR THE DETECTION AND DIAGNOSIS OF PREDIABETES AND TYPE II DIABETES MELLITUS IN REPRODUCTIVE AGE WOMEN WITH POLYCYSTIC OVARY SYNDROME